Skip Navigation

Coronavirus (COVID-19) information for Dana-Farber patients & families Learn more

Hematologic Oncology Cancer Types and Programs

  • The Center for Hematologic Oncology provides specialized care for all types of cancers of the blood, including leukemia, lymphoma, multiple myeloma, histiocytosis, and Waldenström's macroglobulinemia, as well as related disorders of the blood, such as aplastic anemia and myelodysplasia.

    The center also includes the bone marrow/stem cell transplantation program, which is one of the largest and most experienced in the world.

    We develop personalized, comprehensive treatment plans for all our patients, offering the latest therapies and supportive resources, and taking your particular needs into account.

  • Our specialized centers and programs

    Lymphoma Program

    The Lymphoma Program provides care for the many varieties of lymphoid malignancies, including Non-Hodgkin lymphoma (NHL), Hodgkin lymphoma, B-cell neoplasms, and T-cell neoplasms.

    Center for Chronic Lymphocytic Leukemia (CLL)

    The Chronic Lymphocytic Leukemia Program provides care for patients with chronic lymphocytic leukemia (CLL), and offers access to clinical trials of promising new therapies.

    Multiple Myeloma Program

    The Jerome Lipper Multiple Myeloma Center and LeBow Institute for Myeloma Therapeutics provide care to patients with multiple myeloma, including promising new therapies through clinical trials.

    Waldenström's Macroglobulinemia Program

    The Bing Center for Waldenström's Macroglobulinemia provides care and new therapies through clinical trials to patients with Waldenström's macroglobulinemia and related Immunoglobulin M (IgM) disorders.

    Adult Leukemia Program

    The Adult Leukemia Program provides care for patients with leukemia and related bone marrow disorders, including acute myeloid leukemia (AML), acute lymphocytic leukemia (ALL), chronic myelogenous leukemia (CML), and related bone marrow disorders, such as myelodysplasia and myelofibrosis.

    Division of Stem Cell Transplantation and Cellular Therapies

    Our stem cell transplantation program is one of the largest and most experienced transplant centers in the world, and our cellular therapies program is at the forefront of emerging cellular therapies that help the immune system fight cancer such as CAR T-cell therapy, cancer vaccines, NK cell therapy, and genetically-modified immune cells.

    Adult Histiocyte Disorders Center

    The Adult Histiocyte Disorders Center provides highly effective, personalized treatment options for patients with adult histiocytosis and histiocyte disorders – rare diseases resulting from over-production of white blood cells (histiocytes), which can lead to tumors and organ damage.

    Older Adult Hematologic Malignancy (OHM) Program

    The OHM Program is a research and clinical service that addresses the specialized needs of blood cancer patients who are age 75 and older.

    Blastic Plasmacytoid Dendritic Cell Neoplasm (BPDCN) Center

    The BPDCN Center combines world-class patient care with leading-edge research — providing highly effective, personalized treatment options for patients with blastic plasmacytoid dendritic cell neoplasm (BPDCN), a rare and aggressive hematologic malignancy. Our center is among the first in the U.S. for care and research for patients with BPDCN.
  • Center for Prevention of Progression

    The Center for Prevention of Progression is the first-of-its-kind clinic for patients with precursor conditions of hematologic malignancies. Building on our research of precursor conditions, the clinic evaluates individuals diagnosed with these conditions or at high risk for disease development, and works with patients to manage their risk of disease progression.

    Amyloidosis Program

    The Amyloidosis Program is highly specialized and dedicated to the diagnosis, research, and treatment of this underappreciated and often misdiagnosed disease. Our approach to treatment is unique in that it is grounded in science and laboratory-based discovery. We provide access to clinical trials, innovative therapies, and unparalleled patient-centered care.
  • Hematologic malignancies we treat include:

    Agnogenic myeloid metaplasia
    Aids-related malignancies
    Aplastic anemia and paroxysmal nocturnal hemoglobinuria (PNH)
    Autoimmune disorders
    Burkitt lymphoma
    Castleman's syndrome
    Chronic myeloid monocytic leukemia (CMML)
    CNS primary lymphoma
    Congenital disorders of blood production (sickle cell anemia, thalassemia), Blackfan-Diamond, Shwachman-Diamond, and Dyskeratosis Congenita syndromes
    Essential thrombocytosis
    Hairy cell leukemia
    Jak 2 disease
    Langerhans cell histiocytosis
    Lymphoproliferative disorder
    Megablastic anemia
    Monoclonal paraprotein/M-GUS
    Mycosis fungoides/cutt-cell lymphoma
    Myelodysplastic syndromes
    Monoclonal gammmopathies
    Myeloid metaplasia
    Myeloproliferative disorders (polycythemia, myelofibrosis, thrombocythemia)
    Neutropenia pancytopenia
    NK cell lymphoma
    Philadelphia positive disease
    Polycythemia vera
    Testicular cancer
    Testicular choriocarcinoma
    Waldenström's macroglobulinemia

  • Blum Center creative arts program participant

    The Eleanor and Maxwell Blum Patient and Family Resource Center

    The Blum Resource Center provides patients and family members with a comfortable environment to learn more about disease treatment and management.

    fresh fruit and vegetables

    Nutrition Services

    Our nutrition experts help patients follow a healthy diet during and after cancer treatment.

    Join Cancer Connect

    Join Our Online Cancer Community

    Join Dana-Farber's online cancer community and connect with other patients and survivors for support and information.